go to contents

Mycoplasma Biosafety Services GmbH

Back to list

Facts

Founded
2014
Staff
10
Organization type
RDM biotech/pharma
Region
Vienna

Profile

Mycoplasma Biosafety Services GmbH is a leading contract research organization which is worldwide one of the few suppliers specializing in GMP-compliant mycoplasma biosafety testing of cell banks and biopharmaceutical products including vaccines and ATMPs. The company is also a manufacturer and supplier of ready-to-use high-quality mycoplasma culture media products and mycoplasma reference standards for routine mycoplasma testing, test validations and process validations for mycoplasma removal.

R&D:With a top-notch cluster of mycoplasma experts in the company, Mycoplasma Biosafety, is dedicated to research and development in future fields. In nationally funded research projects, the R&D team develops novel testing methods specific for blood-derived products and innovative Mycoplasma Culture Media for quality control testing as well as for vaccine development.

Production:In the context of the mycoplasma testing portfolio Mycoplasma Biosafety develops and produces Mycoplasma Culture Media and Mycoplasma Reference Standards for quality control testing. Both product categories are offered in a broad variety and produced under GMP-conditions and approved for usage in regulatory mycoplasma testing in the biopharmaceutical industry.

Services:As technological market leader in mycoplasmology, Mycoplasma Biosafety offers reliable mycoplasma testing for quality control in the biopharmaceutical industry. Another specialized service is the customer-specific validation of alternative mycoplasma testing methods, such as qPCR, in accordance with the European or other national Pharmacopoeiae. Furthermore, the company offers a broad range of consulting services provided by the in-house experts.

Sales/Distribution:Mycoplasma Biosafety offers its services and products all around the world. In Europe, the products are distributed directly. Wako Pure Chemicals is responsible for the distribution of Mycoplasma Biosafety’s products in Japan.

Similar companies in RDM biotech/pharma

Daiichi Sankyo Austria GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Details

Aposcience AG

Organization type
RDM biotech/pharma
Region
Vienna
Details

Ares Genetics

Organization type
RDM biotech/pharma
Region
Vienna
Details

Pfizer Corporation Austria GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Details

Contact

Muthgasse 11/2
1190 Vienna
Vienna

Contact: Martina Sauer (PhD, Business Development, COO)
Telephone: +43 (1) 3672045-0
Email: office@mycoplasma.cc
Website